Real-World Dosing Patterns in Patients with Anaplastic Lymphoma Kinase Positive ( ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated with Brigatinib in the Front-Line(FL) Setting in the United States: A Claims Database Analysis
07:30am - 03:45pm EDT - April 1, 2023